MedPath

Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo

Not Applicable
Completed
Conditions
Vertigo
Registration Number
NCT05118659
Lead Sponsor
Centro Universitario La Salle
Brief Summary

This analysis aims to evaluate the immediate effect that cervical sustained natural apophyseal glides (SNAGs) have on a group of individuals with induced vertigo by a caloric vestibular stimulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Healthy subjects,
  • Age 18-44 years.
Exclusion Criteria
  • Consume of antipsychotics, antidepressants, antiarrythmics and/or anticonvulsivants
  • Hippoacusia
  • Auditory diseases
  • Peripheral or central vestibulopathies
  • Cerviogenic dizziness
  • Balance disorders
  • Nistagmus
  • Oculomotor nerve dysfunctions
  • Migraine
  • Cervical osteoporosis, lashing or fracture
  • Discal cervical hernia
  • Cervical neuropathy
  • Psychriatic disorders
  • Epilepsy
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
vHIT (Video Head Impulse Test)15 minutes

Detection of peripheral vestibular deficits and their recovery

Secondary Outcome Measures
NameTimeMethod
Anxiety5 minutes

state-trait anxiety was measured at the beginning of the study using the Spanish version of the trait-state anxiety inventory (STAI)

Trial Locations

Locations (2)

CSEU La Salle

🇪🇸

Madrid, Spain

Jose V Leon Hernandez

🇪🇸

Madrid, Spain

CSEU La Salle
🇪🇸Madrid, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.